Patients who receive Moderna’s COVID-19 vaccine produce twice the protective antibodies of those who receive Pfizer’s, a new study from a major Belgium hospital finds.
Patients who receive Moderna’s COVID-19 vaccine produce twice the protective antibodies of those who receive Pfizer’s, a new study from a major Belgium hospital finds.